Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

7:08 AM ET 8-K
Financial Results Frontdoor, Inc. FTDR

Frontdoor Financial Results

Frontdoor, Inc. reported third-quarter 2026 revenue of $655 million, a 6% increase year-over-year, and net income of $116 million. The company raised its full-year 2026 outlook and announced a new $1 billion share repurchase authorization following strong cash flow generation.

Term
Q3 2026

“I am proud of how our team produced strong third-quarter results while providing exceptional service for our members during the hottest summer on record. Our team continues to rise to the challenge and find new ways to improve our operations and elevate the member experience. These outcomes reflect the value we provide homeowners, the dedication of our people, and the durability of our business model.”

Bill Cobb, Chairman and Chief Executive Officer

“We delivered higher revenue, Adjusted EBITDA and earnings per share again in the third quarter. Our capital-light business continued to generate strong cash flows and enabled us to accelerate share repurchases in the third-quarter. We now expect to complete our current authorization in November. As a result, our Board of Directors approved a new $1 billion authorization, which reflects our confidence in the business and underscores our commitment to returning excess cash to shareholders.”

Jason Bailey, Chief Financial Officer
7:08 AM ET 8-K
Financial Results Avalo Therapeutics, Inc. AVTX

Avalo Therapeutics Financial Results

Avalo Therapeutics reported its third quarter 2026 financial results, highlighting a cash position of $462.8 million which is expected to fund operations into 2029. The company is advancing its lead candidate, abdakibart, toward a Phase 3 program in hidradenitis suppurativa with initiation planned for the first half of 2027.

“LOTUS provides a strong clinical foundation for advancing abdakibart toward registrational development in hidradenitis suppurativa. The efficacy and safety results observed across both dosing regimens, together with the potential for once-monthly administration, give us confidence in abdakibart’s potential to become an important new treatment option for patients with HS.”

Garry Neil, MD, Chief Executive Officer
7:08 AM ET 8-K
Financial Results Unity Software Inc. U

Unity Software Financial Results

Unity Software reported its third quarter 2026 financial results, achieving its first GAAP profitable quarter since its IPO with net income of $122 million. Total revenue grew 32% year-over-year to $622 million, driven by a 59% increase in strategic revenue and strong performance in the Grow Solutions segment.

Term
Q3 2026

“Third-quarter performance was our strongest ever, with Vector growing 126% year-over-year and 40% quarter-over-quarter, and the first GAAP profitable quarter since our IPO.”

Matt Bromberg, President and CEO of Unity

“We are seeing the compounding impact of our flywheel strategy: more creators make more games on our platform, and more games fuel the need for more discovery through advertising.”

Matt Bromberg, President and CEO of Unity
7:08 AM ET 8-K
Financial Results Lexicon Pharmaceuticals, Inc. LXRX

Lexicon Pharmaceuticals Financial Results

Lexicon Pharmaceuticals reported Q3 2026 financial results and provided clinical updates, including the completion of enrollment for its Phase 3 SONATA-HCM study. The company also confirmed it has achieved the safety data requirements for its ZYNQUISTA NDA resubmission in type 1 diabetes.

Term
3 months

“This quarter brought Lexicon into sharper focus as a cardiometabolic company and has positioned us to approach 2027 with strong momentum and multiple near-term potential catalysts and paths to value creation.”

Mike Exton, Ph.D., Lexicon’s chief executive officer and director

“As we prepare for several important milestones across our portfolio, we remain focused on investing prudently to support execution and position the Company for long-term success.”

Scott Coiante, Lexicon’s chief financial officer
7:08 AM ET 8-K
Financial Results Middleby Corp MIDD

Middleby Financial Results

Middleby Corp reported record Q3 2026 net sales of $653 million, representing 7.7% organic growth, and raised its full-year organic sales growth guidance to 7-8%. The company also announced a leadership transition where Steve Spittle will succeed Tim FitzGerald as CEO on April 1, 2027, following the successful separation of its Food Processing business.

Term
Q3 2026

“We delivered record third quarter net sales and strong organic growth across our commercial foodservice business. Adjusted EBITDA increased 10% from the prior year, and our performance exceeded the high end of our guidance ranges for net sales, Adjusted EBITDA and Adjusted EPS. These results reflect the benefits of our strategic investments, industry-leading innovation and continued focus on customer-driven solutions.”

Tim FitzGerald, CEO of the Middleby Corporation

“Following the successful separation of our Food Processing business and the launch of Midera as an independent public company, Middleby is now a focused, pure-play commercial foodservice leader. We remain committed to disciplined capital allocation and repurchased 1.0 million shares during the third quarter and 4.8 million shares year to date. Our strong third quarter performance and continued business momentum give us confidence to raise our full year 2026 guidance.”

Tim FitzGerald, CEO of the Middleby Corporation
7:08 AM ET 8-K
Financial Results Global Payments Inc GPN

Global Payments Financial Results

Global Payments reported third quarter 2026 GAAP revenue of $3.31 billion and adjusted EPS of $3.58, representing a 10% increase. The company reaffirmed its full-year 2026 outlook and increased its run-rate expense synergy target for the Worldpay integration to $650 million.

Term
Q3 2026

“We delivered third quarter results consistent with our expectations, reflecting the ongoing disciplined execution of our team members worldwide. We continue to make substantial progress integrating Worldpay, giving us confidence to increase our run-rate expense synergy target to $650 million.”

Cameron Bready, chief executive officer

“Our third quarter financial performance demonstrates the durability of our business model and our ability to generate sustainable growth, margin expansion and strong free cash flow.”

Josh Whipple, chief financial officer
7:08 AM ET 8-K
Financial Results Rockwell Automation, Inc ROK

Rockwell Automation Financial Results

Rockwell Automation reported fiscal 2026 full-year results with reported sales up 8% to $9.4 billion and Adjusted EPS increasing 27% to $13.42. The company introduced fiscal 2027 guidance projecting organic sales growth of 6% to 9% and Adjusted EPS between $14.50 and $15.50.

Term
FY2026

“Rockwell delivered a strong finish to a great year, with broad-based topline growth, margin expansion, and double-digit earnings growth. Our results underscore the differentiation of our strategy and operating model, as we continue to gain share, strengthen our leadership in core markets, and expand our position in high-growth areas including semiconductor and data centers.”

Blake Moret, Chairman and CEO
7:08 AM ET 8-K
Financial Results Shift4 Payments, Inc. FOUR

Shift4 Payments Financial Results

Shift4 Payments, Inc. reported its financial results for the third quarter ended September 30, 2026. The company provided detailed non-GAAP metrics including gross revenue less network fees, Adjusted EBITDA, and Adjusted Free Cash Flow to evaluate its performance in the 'Experience Economy'.

Term
Q3 2026
7:08 AM ET 8-K
Financial Results Monte Rosa Therapeutics, Inc. GLUE

Monte Rosa Therapeutics Financial Results

Monte Rosa Therapeutics reported Q3 2026 financial results, highlighting a cash position of $582.6 million and $87.5 million in milestone payments triggered by Novartis initiating Phase 2 studies for MRT-6160. The company also announced positive Phase 1 data for MRT-8102 in cardiovascular disease and the initiation of multiple Phase 2 clinical trials across its pipeline.

Counterparty
Novartis
Term
3 months

“The last quarter marks a tremendously important step forward for our clinical portfolio, with a positive readout from the GFORCE-1 study of MRT-8102, the initiation of Phase 2 development for MRT-2359, and the advancement of our partnered VAV1 program into two Phase 2 studies.”

Markus Warmuth, M.D., Chief Executive Officer of Monte Rosa Therapeutics

“We are particularly excited about the opportunity in gout, where there is a substantial unmet need for effective flare prevention that is well tolerated with prolonged use.”

Markus Warmuth, M.D., Chief Executive Officer of Monte Rosa Therapeutics
7:08 AM ET 8-K
Financial Results Cartesian Therapeutics, Inc. RNAC

Cartesian Therapeutics Financial Results

Cartesian Therapeutics reported Q3 2026 financial results, ending the period with $124.7 million in cash to support operations into 2028. The company is advancing its Phase 3 AURORA trial for Descartes-08 in myasthenia gravis with data expected in Q1 2027 and a BLA filing planned for mid-2027.

Term
Q3 2026

“With Phase 3 AURORA data expected in the first quarter of 2027, our focus this quarter remains on execution, both in the clinic and in preparing the organization for a commercial launch. Ahead of our anticipated BLA submission in mid-2027, we have expanded our medical affairs and commercial teams to drive launch readiness.”

Carsten Brunn, Ph.D., President and Chief Executive Officer
7:08 AM ET 8-K
Financial Results BKV Corp BKV

BKV Financial Results

BKV Corp reported Q3 2026 net income of $29.4 million and average net production of 981.2 MMcfe/d. The company also announced a cost reimbursement agreement with a leading frontier AI lab to support doubling planned modular power generation at the Temple Energy Complex to 400 MW.

Term
Q3 2026
7:07 AM ET 10-Q
Financial Results Shutterstock, Inc. SSTK

Shutterstock Q3 2026 Results: Net Loss of $198M

Shutterstock, Inc. filed its Form 10-Q for the period ending September 30, 2026, providing a detailed overview of its quarterly financial performance and operational results. The report includes condensed consolidated financial statements and management's discussion on the company's liquidity and capital resources.

Key figure
Net loss $198M
7:07 AM ET 10-Q
Financial Results Real Remax Group Inc. REAX

Real Remax Group Q3 2026 Results: Net Loss of $67.3M, Loss Widens

Real REMAX Group Inc. reported a significant increase in revenue to $1.89 billion for the first nine months of 2026, up from $1.46 billion in the prior year, following the combination of the Real and REMAX businesses. However, the company incurred a substantial net loss of $78.8 million during this period, driven by $64.2 million in acquisition and integration expenses and increased interest costs from new debt.

Key figure
Net loss $67.3M
7:07 AM ET 8-K
Financial Results Malibu Boats, Inc. MBUU

Malibu Boats Financial Results

Malibu Boats reported financial results for the three months ended September 30, 2026, with net sales increasing 29.9% to $252.9 million, driven largely by the Saxdor acquisition. The company swung to a GAAP net income of $6.1 million from a loss in the prior year, despite a softer retail environment in the ski/wake boat category. Additionally, the Board approved a change in the company's fiscal year end from June 30 to December 31.

Term
Q1 2027

“Our results for the three months ended September 30, 2026 reflect a softer retail environment over the summer and our decision to manage wholesale shipments with discipline to protect dealer health, which kept net sales modestly below our guided range and constrained adjusted EBITDA.”

Steve Menneto, President and Chief Executive Officer

“Our balance sheet gives us the flexibility to support the business through the cycle. The refinancing we completed in July extended our maturity to 2031, and we ended the quarter with approximately $213.5 million available of liquidity.”

David Black, Chief Financial Officer
7:07 AM ET 8-K
Financial Results Fate Therapeutics Inc FATE

Fate Therapeutics Financial Results

Fate Therapeutics reported third-quarter 2026 financial results, highlighting a cash position of $139.1 million and a runway extending into mid-2028. The company is advancing its RECLAIM-LN Phase 2 trial for FT819 in lupus nephritis and recently received a $15 million grant from the California Institute for Regenerative Medicine (CIRM) to support the program.

Term
Q3 2026

“The third quarter was defined by steady execution across our portfolio, bringing us closer to our goal of delivering off-the-shelf, master cell bank derived cell therapies to the patients who need them most.”

Bob Valamehr, Ph.D., MBA, President and Chief Executive Officer

“Our progress this year, together with continued extension of our cash runway, positions us well for important milestones ahead, and we remain focused on execution as we work to deliver across multiple fronts in 2027.”

Bob Valamehr, Ph.D., MBA, President and Chief Executive Officer
7:07 AM ET 8-K
Financial Results BlackSky Technology Inc. BKSY

BlackSky Technology Financial Results

BlackSky Technology reported record third-quarter 2026 revenue of $43 million, a 118% year-over-year increase driven by strong demand for its Gen-3 space-based intelligence services. The company achieved profitability with net income of $19 million and record Adjusted EBITDA of $13 million, leading management to raise its full-year 2026 financial guidance.

Term
Q3 2026

“Building on strong Gen-3 sales performance, we delivered an exceptional third quarter with record revenue, strong margin growth, and record adjusted EBITDA. Real-time intelligence is more mission-critical than ever, and we are winning customers because of our demonstrated ability to deliver assured, actionable intelligence with speed, reliability, and clarity.”

Brian E. O’Toole, BlackSky CEO
7:07 AM ET 8-K
Financial Results Nexstar Media Group, Inc. NXST

Nexstar Media Group Financial Results

Nexstar Media Group reported record third-quarter net revenue of $2.1 billion, a 78% increase year-over-year, driven by the acquisition of TEGNA, Inc. and record political advertising revenue. The company generated net income of $250 million and Adjusted Free Cash Flow of $443 million, while reducing debt by $1.3 billion year-to-date.

Term
Q3 2026

“Nexstar delivered the highest quarterly net revenue in the Company’s history, reflecting the acquisition of TEGNA, Inc. and strong distribution and advertising revenue performance, including all-time high third-quarter political advertising revenue.”

Perry A. Sook, Founder, Chairman and CEO

“Our strong operating performance for the first nine months of the year generated $1.1 billion in Adjusted Free Cash Flow, enabling us to reduce debt by $786 million and return $171 million to shareholders through dividends, while also funding ongoing investments in local news and sports programming.”

Perry A. Sook, Founder, Chairman and CEO
7:07 AM ET 8-K
Financial Results Korsana Biosciences, Inc. KRSA

Korsana Biosciences Financial Results

Korsana Biosciences reported third quarter 2026 financial results, highlighting a cash position of $456.2 million following its merger with Cyclerion Therapeutics and a $380 million private placement. The company expects its current capital to fund operations into 2029 as it advances its lead Alzheimer's candidate, KRSA-028, toward Phase 1 clinical data in mid-2027.

Term
Q3 2026

“The third quarter was transformative for Korsana, providing us with the financial resources and experienced leadership team to execute our strategy. With this foundation in place, we remain focused on advancing KRSA-028 toward the clinic and building the body of evidence supporting the program, including through our first preclinical poster at CTAD later this month.”

Jonathan Violin, Ph.D., President and Chief Executive Officer
7:07 AM ET 10-Q
Financial Results Core Natural Resources, Inc. CNR

Core Natural Resources Q3 2026 Results: Net Income $9M, Down 71.5% YoY

Core Natural Resources, Inc. filed this Form 10-Q on November 5, 2026, following its formation through the merger of Arch Resources and CONSOL Energy. The report provides quarterly financial results and operational updates for the combined entity's coal production and export activities.

Key figure
Net income $9M · -71.5% YoY
7:07 AM ET 8-K
Financial Results Entrada Therapeutics, Inc. TRDA

Entrada Therapeutics Financial Results

Entrada Therapeutics reported third quarter 2026 financial results and provided updates on its clinical pipeline, including its ELEVATE-44-201 and ELEVATE-45-201 programs for Duchenne muscular dystrophy. The company ended the quarter with $193 million in cash, extending its expected runway into Q4 2027. Multiple clinical data readouts are expected through the first half of 2027, including data from its DM1 partnership with Vertex.

“The October Cohort 1 data from ELEVATE-45-201 marked our third consecutive readout demonstrating encouraging safety and tolerability across our clinical programs. With these initial dose cohorts supporting the safety profile of our lead Duchenne programs, our attention now turns to the next set of readouts designed to further define the potential of our investigational medicines.”

Dipal Doshi, Chief Executive Officer of Entrada Therapeutics

“Including the anticipated Phase 1/2 clinical data from our partner Vertex’s GALILEO study in myotonic dystrophy type 1 during the second half of 2026, we expect four clinical data readouts through the first half of 2027. This marks an important period of clinical catalysts for Entrada as we advance our pipeline and work toward our goal of delivering potentially transformative medicines to people living with serious neuromuscular diseases.”

Dipal Doshi, Chief Executive Officer of Entrada Therapeutics
7:07 AM ET 8-K
Financial Results Resolute Holdings Management, Inc. RHLD

Resolute Holdings Management Financial Results

Resolute Holdings Management reported Q3 2026 financial results, highlighting a significant increase in Non-GAAP Fee-Related Earnings to $0.69 per share compared to $0.13 in the prior year. The company also announced that its board of directors authorized an increase to its share repurchase program to $100.0 million with no expiration date.

7:07 AM ET 8-K
Financial Results Bentley Systems Inc BSY

Bentley Systems Financial Results

Bentley Systems reported third quarter 2026 total revenues of $421.5 million, representing a 12.2% year-over-year increase. The company achieved a constant currency ARR growth rate of 13%, which exceeded its annual outlook range, driven by strength in Resources and Public Works & Utilities sectors.

Term
Q3 2026

“The progression throughout 2026 to date of BSY’s year-over-year ARR growth rate to 13%, exceeding our annual outlook range, reflects both the robustness of our focused end markets, and accounts’ confidence in our mutual trajectories for infrastructure AI.”

Greg Bentley, Executive Chair

“We delivered another quarter of accelerated growth, driven by strength in Resources and continued momentum in Public Works & Utilities. The engineering firms we serve are benefiting from an unprecedented level of investment in infrastructure for AI.”

Nicholas Cumins, CEO
7:07 AM ET 8-K
Financial Results Commerce.com, Inc. CMRC

Commerce.com Financial Results

Commerce.com, Inc. reported Q3 2026 financial results with total revenue of $84.2 million and total ARR of $357.6 million. The company also announced that CFO/COO Daniel Lentz will step down on November 13, 2026, with Tyler Duncan appointed as Interim CFO.

Term
Q3 2026

“Our third quarter results reflect another period of disciplined execution, with total ARR of $357.6 million, 14% GMV growth to $9.0 billion, and $9.4 million in operating cash flow.”

Travis Hess, CEO of Commerce

“Just as important, the strategic operating plan we initiated in September is driving greater efficiency and profitability while protecting investments in our highest-impact growth areas: product intelligence, AI-driven agentic commerce and the open architecture merchants need as commerce becomes increasingly distributed.”

Travis Hess, CEO of Commerce
7:06 AM ET 10-Q
Financial Results Cartesian Therapeutics, Inc. RNAC

Cartesian Therapeutics Q3 2026 Results: Net Loss of $11.5M, Loss Narrows

Cartesian Therapeutics reported its third-quarter 2026 results, highlighting continued investment in its mRNA cell therapy pipeline, specifically lead candidate Descartes-08. The company maintained a strong cash position to fund operations into 2027, despite a net loss driven by increased clinical trial expenses.

Key figure
Net loss $11.5M
7:06 AM ET 8-K
Financial Results Core Scientific, Inc. CORZ

Core Scientific Financial Results

Core Scientific reported third quarter 2026 financial results, highlighted by a nearly 60% sequential increase in colocation revenue to $215.4 million. The company achieved net income of $1.2 billion, primarily driven by a non-cash gain from the change in fair value of warrants, and significantly expanded its Adjusted EBITDA margins to 57%.

“Our execution at scale is translating into results, with a significant sequential increase in GAAP colocation revenue. We are nearing full delivery under our first colocation agreement while construction under our second is underway across five campuses. With revenue growing and substantial contracted capacity still to deliver, we have built a strong foundation for our next phase of growth.”

Adam Sullivan, Chief Executive Officer of Core Scientific
7:06 AM ET 10-Q
Financial Results Avalo Therapeutics, Inc. AVTX

Avalo Therapeutics Q3 2026 Results: Net Loss of $18.9M, Loss Narrows

Avalo Therapeutics reported its quarterly financial results for the period ended September 30, 2026, highlighting the continued clinical development of its lead immunology assets. The filing details research and development expenses, net losses, and the company's current liquidity position as it pursues key pipeline milestones.

Key figure
Net loss $18.9M
7:06 AM ET 10-Q
Financial Results News Corp NWSA

News Q1 2026 Results: Net Income $159M, Up 42.0% YoY

News Corp reported its quarterly financial results for the period ended September 30, 2026, highlighting performance across its key segments including Dow Jones and Digital Real Estate Services. The filing details consolidated revenues and net income, reflecting ongoing digital transformation and subscription growth strategies.

Key figure
Net income $159M · +42.0% YoY
7:02 AM ET 8-K
Financial Results Core Natural Resources, Inc. CNR

Core Natural Resources Financial Results

Core Natural Resources reported Q3 2026 net income of $9.0 million on revenues of $1.1 billion, driven by its thermal and metallurgical coal segments. The company returned $90 million to stockholders during the quarter through share repurchases and dividends, while securing 29.4 million tons of future sales commitments.

“Core continues to demonstrate the power of its highly cash-generative portfolio of world-class assets and its strategic engagement in the most compelling segments of the global marketplace.”

Jimmy Brock, Core’s chairman and CEO

“During Q3, the Core team again generated robust free cash flow and returned a substantial amount of capital to stockholders for the seventh straight quarter.”

Jimmy Brock, Core’s chairman and CEO
7:00 AM ET 8-K
Financial Results Peloton Interactive, Inc. PTON

Peloton Interactive Financial Results

Peloton reported Q1 FY2027 financial results with revenue of $559 million, marking its third consecutive quarter of year-over-year growth. The company achieved GAAP net income of $96 million and significantly improved its balance sheet by reducing gross principal debt by 32% during the 2026 calendar year.

Term
Q1 FY2027

“Our Q1 results underscore the strength of our business and reinforce the trajectory of our multi-year transformation. Our purposeful innovation has enabled us to target the multibillion-dollar at-home treadmill market with our best products and broadest price range ever, advance digital personalized training through Peloton IQ, and launch the Peloton Commercial Series to meet Members wherever they train.”

Peter Stern, Peloton's CEO and President

“We began the fiscal year by demonstrating that our financial engine is operating efficiently in the short-term while positioning us for the future. Our performance across the top and bottom lines is testament to our disciplined approach on cost along with continued strong Member engagement and strength in our commercial business.”

Sid Thacker, Peloton’s Chief Financial Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.